Luigi Marcheselli

6.8k total citations · 1 hit paper
143 papers, 3.8k citations indexed

About

Luigi Marcheselli is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Luigi Marcheselli has authored 143 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Pathology and Forensic Medicine, 61 papers in Oncology and 27 papers in Genetics. Recurrent topics in Luigi Marcheselli's work include Lymphoma Diagnosis and Treatment (69 papers), Viral-associated cancers and disorders (31 papers) and Chronic Lymphocytic Leukemia Research (23 papers). Luigi Marcheselli is often cited by papers focused on Lymphoma Diagnosis and Treatment (69 papers), Viral-associated cancers and disorders (31 papers) and Chronic Lymphocytic Leukemia Research (23 papers). Luigi Marcheselli collaborates with scholars based in Italy, Israel and Ukraine. Luigi Marcheselli's co-authors include Massimo Federico, Stefano Luminari, Stefano Sacchi, Paola Ferri, Francesco Merli, Samantha Pozzi, Alessia Bari, Rosaria Di Lorenzo, Lorenzo Tassi and Luca Baldini and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Luigi Marcheselli

138 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

2009 506 citations Massimo Federico, Monica Bellei et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luigi Marcheselli Italy	31	2.2k	1.7k	683	567	567	143	3.8k
Ingrid Glimelius Sweden	30	916 0.4×	1.7k 1.0×	209 0.3×	178 0.3×	638 1.1×	181	3.6k
John M. Burke United States	27	975 0.4×	1.2k 0.7×	672 1.0×	199 0.4×	472 0.8×	177	3.1k
Monika L. Metzger United States	34	705 0.3×	846 0.5×	242 0.4×	483 0.9×	697 1.2×	139	4.3k
Michael L. Nieder United States	30	418 0.2×	1.0k 0.6×	631 0.9×	278 0.5×	780 1.4×	88	3.8k
S. Ashley United Kingdom	47	1.1k 0.5×	3.1k 1.8×	1.0k 1.5×	436 0.8×	2.1k 3.7×	127	7.1k
Martin D. Abeloff United States	41	804 0.4×	3.1k 1.9×	460 0.7×	346 0.6×	988 1.7×	119	6.4k
Saro H. Armenian United States	44	513 0.2×	1.7k 1.0×	260 0.4×	373 0.7×	826 1.5×	238	5.9k
W. Archie Bleyer United States	41	412 0.2×	1.2k 0.7×	870 1.3×	692 1.2×	934 1.6×	93	5.5k
Raymond B. Weiss United States	31	648 0.3×	2.1k 1.3×	228 0.3×	226 0.4×	786 1.4×	84	3.7k
Eric J. Chow United States	41	337 0.2×	1.5k 0.9×	303 0.4×	487 0.9×	813 1.4×	201	6.6k

Countries citing papers authored by Luigi Marcheselli

Since Specialization

Citations

This map shows the geographic impact of Luigi Marcheselli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Marcheselli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Marcheselli more than expected).

Fields of papers citing papers by Luigi Marcheselli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luigi Marcheselli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Marcheselli. The network helps show where Luigi Marcheselli may publish in the future.

Co-authorship network of co-authors of Luigi Marcheselli

This figure shows the co-authorship network connecting the top 25 collaborators of Luigi Marcheselli. A scholar is included among the top collaborators of Luigi Marcheselli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luigi Marcheselli. Luigi Marcheselli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Toss, Angela, Elena Tenedini, Alessandra Bologna, et al.. (2021). The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results from a Multicenter Cohort Study. Diagnostics. 11(3). 565–565. 5 indexed citations

Toss, Angela, Eleonora Molinaro, Marta Venturelli, et al.. (2020). BRCA Detection Rate in an Italian Cohort of Luminal Early-Onset and Triple-Negative Breast Cancer Patients without Family History: When Biology Overcomes Genealogy. Cancers. 12(5). 1252–1252. 19 indexed citations

Marcheselli, Raffaella, Alessia Bari, Tamar Tadmor, et al.. (2020). Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma. Hematological Oncology. 38(4). 439–445. 5 indexed citations

Foss, Francine M., Steven M. Horwitz, Monica Civallero, et al.. (2019). Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas. American Journal of Hematology. 95(2). 151–155. 38 indexed citations

Anastasia, Antonella, Annalisa Chiarenza, Luigi Marcheselli, et al.. (2019). Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL). British Journal of Haematology. 185(4). 713–717. 18 indexed citations

Salati, Massimiliano, Francesco Catanzariti, Krisida Cerma, et al.. (2019). The impact of gender and immune system determinants on long-term survival in biliary tract cancer. 5(1). 27–30.

Bellei, Monica, Francine M. Foss, Andrei R. Shustov, et al.. (2018). The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project. Haematologica. 103(7). 1191–1197. 88 indexed citations

Cosenza, Maria, Monica Civallero, Luigi Marcheselli, Stefano Sacchi, & Samantha Pozzi. (2017). Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine. APOPTOSIS. 22(6). 827–840. 38 indexed citations

Silingardi, Roberto, Stefano Gennai, Giovanni Coppi, et al.. (2017). Contemporary economic and clinical evaluations of endovascular repair for intact descending thoracic aortic aneurysms. The Journal of Cardiovascular Surgery. 58(6). 835–844. 2 indexed citations

10.

Toss, Angela, Giovanni Grandi, Luigi Marcheselli, et al.. (2016). The impact of reproductive factors and oral contraception on breast cancer risk in women with brca mutation or family history of breast cancer. Annals of Oncology. 27. iv59–iv59. 1 indexed citations

11.

Ferri, Paola, et al.. (2015). Empathy and burnout: an analytic cross-sectional study among nurses and nursing students.. PubMed. 86 Suppl 2. 104–15. 96 indexed citations

12.

Silingardi, Roberto, Antonio Lauricella, Giovanni Coppi, et al.. (2015). Durability and Efficacy of Tibial Arterial Stent Placement for Critical Limb Ischemia. Journal of Vascular and Interventional Radiology. 26(4). 475–483.e2. 4 indexed citations

13.

Mian, Michael, Luigi Marcheselli, Andrea Rossi, et al.. (2014). A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma. Annals of Oncology. 25(12). 2398–2404. 10 indexed citations

14.

Merli, Francesco, Stefano Luminari, Giuseppe Rossi, et al.. (2013). Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi. Leukemia & lymphoma. 55(1). 38–43. 56 indexed citations

15.

Cortesi, Laura, et al.. (2012). Outcome evaluation in pre-trastuzumab era between different breast cancer phenotypes: a population-based study on Italian women.. PubMed. 98(6). 743–50. 7 indexed citations

16.

Solal‐Céligny, Philippe, Monica Bellei, Luigi Marcheselli, et al.. (2012). Watchful Waiting in Low–Tumor Burden Follicular Lymphoma in the Rituximab Era: Results of an F2-Study Database. Journal of Clinical Oncology. 30(31). 3848–3853. 88 indexed citations

17.

Bari, Alessia, et al.. (2011). THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS. SHILAP Revista de lepidopterología. 3(1). e2011065–e2011065. 8 indexed citations

18.

Bari, Alessia, Luigi Marcheselli, Stefano Sacchi, et al.. (2009). Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story. Annals of Oncology. 21(7). 1486–1491. 77 indexed citations

19.

Sacchi, Stefano, Luigi Marcheselli, Alessia Bari, et al.. (2008). Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study. Haematologica. 93(9). 1335–1342. 29 indexed citations

20.

Goldaniga, Maria, Andrea Ferrario, Sergio Cortelazzo, et al.. (2005). CD5 negative chronic B cell leukemias : a polycentric retrospective study. Haematologica. 90. 119–119. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact